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Summary
Activationofmanyprotein kinasesdependson their in-
teraction with the Hsp90molecular chaperone system.
Recruitment of protein kinase clients to the Hsp90
chaperone system is mediated by the cochaperone
adaptor protein Cdc37, which acts as a scaffold, simul-
taneously binding protein kinases andHsp90.Wehave
now expressed and purified an Hsp90-Cdc37-Cdk4
complex, defined its stoichiometry, and determined
its3Dstructurebysingle-particle electronmicroscopy.
Comparison with the crystal structure of Hsp90 allows
us to identify the locations of Cdc37 and Cdk4 in the
complex and suggests a mechanism by which confor-
mational changes in the kinase are coupled to the
Hsp90 ATPase cycle.
Introduction
Association with the Hsp90 molecular chaperone system
is an essential prerequisite for activation of an important
set of protein kinases in the eukaryotic cell. The list of
Hsp90’s kinase ‘‘clientele’’ includes key regulators
such as PKB/Akt (Basso et al., 2002; Fontana et al.,
2002; Sato et al., 2000), PDK1 (Fujita et al., 2002), LKB1
(Boudeau et al., 2003), Raf-1 (Grammatikakis et al.,
1999; Schulte et al., 1995; Stancato et al., 1993), ErbB2
(Xu et al., 2001), Src-family kinases (Bijlmakers and
Marsh, 2000; Xu and Lindquist, 1993; Xu et al., 1999), Au-
rora B (Lange et al., 2002), RIP (Lewis et al., 2000), com-
ponents of the IkB kinase complex (Chen et al., 2002),
and the cyclin-dependent kinases Cdk4, Cdk6, and
Cdk9 (Mahony et al., 1998; O’Keeffe et al., 2000; Stepa-
nova et al., 1996). In all cases analyzed, the Hsp90-
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dent on the ATPase cycle of the chaperone (Prodromou
et al., 2000) so that pharmacological inhibition by Hsp90
binding ATP competitors (Prodromou et al., 1997; Roe
et al., 1999; Stebbins et al., 1997) prevents client activa-
tion. As disregulation of many of these kinases is directly
implicated in development and progression of cancer
(Workman, 2004), understanding the molecular basis
for kinase activation by Hsp90 is key to the development
of new cancer chemotherapies.
Recruitment of kinases to Hsp90 depends on Cdc37
(also known as p50cdc37), originally discovered as a
component of an Hsp90 complex with the viral oncogene
v-Src (Brugge, 1986). Subsequently, Cdc37 has been
found associated with essentially all protein kinases
whose activation is Hsp90 dependent (Pearl, 2005), in-
cluding the cyclin-dependent kinase Cdk4 (Dai et al.,
1996; Lamphere et al., 1997; Stepanova et al., 1996).
Overexpression of Cdc37 is itself oncogenic, reflecting
its association with many pro-oncogenic kinases and
suggesting that their Cdc37-dependent recruitment to
the Hsp90 system may be limiting to their transforming
potential (Stepanova et al., 2000a, 2000b). Cdc37 acts
as a protein kinase-specific adaptor, recruiting client
protein kinases to the Hsp90 system (Silverstein et al.,
1998). Interaction of Cdc37 with protein kinases is medi-
ated by the N-terminal segment (Grammatikakis et al.,
1999; Shao et al., 2003a), while the middle and C-terminal
regions of Cdc37 mediate interaction with Hsp90 (Roe
et al., 2004; Shao et al., 2001; Zhang et al., 2004).
As with some other Hsp90 cochaperones, Cdc37 reg-
ulates the conformationally coupled ATPase mechanism
of Hsp90, arresting the chaperone cycle in the client-
loading phase, prior to Hsp90’s ATP-dependent N-termi-
nal dimerization (Siligardi et al., 2002; Roe et al., 2004).
Cdc37 binds to the ‘‘lid’’ segment in the N-terminal do-
main of Hsp90, preventing its closure over the nucleotide
binding site and locking the N-terminal domains of the
chaperone apart. This prevents the formation of the
N-terminally dimerized ‘‘tense’’ conformation of Hsp90
engendered by ATP binding (Chadli et al., 2000; Prodro-
mou et al., 2000). Considerably less well understood is
the basis of Cdc37’s specific and selective binding to
protein kinase clients. Minimally, the intact N-terminal
lobe of the kinase is required for interaction with Cdc37
(Prince and Matts, 2004; Scroggins et al., 2003) and the
conserved glycine-rich loop plays a role in the interaction
(Zhao et al., 2004). However, this feature is present in
many protein kinases that are not Hsp90 clients and
does not explain the high specificity of Cdc37. Similarly,
the location of the interaction between the client kinase
and Hsp90 itself in a Cdc37-scaffolded complex is also
poorly described. Mutagenesis studies suggest involve-
ment of residues in the middle segment of the chaperone
(Basso et al., 2002; Fontana et al., 2002; Meyer et al.,
2003; Sato et al., 2000), but the nature of the interaction
and how Hsp90 association activates the bound kinase
remains obscure.
Key to understanding the Hsp90/Cdc37-dependent
activation of protein kinase clients is the ability to study
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in vitro. We have developed a recombinant system that
allows production of assembled ternary Hsp90-Cdc37-
kinase complexes at a milligram level. Using this, we
have purified an Hsp90-Cdc37-Cdk4 complex to homo-
geneity, defined its stoichiometry, and determined its 3D
structure by single-particle reconstruction from nega-
tive-stain electron microscopy (EM). Comparison with
the crystal structure of an Hsp90 dimer in the ATP bound
conformation (Ali et al., 2006) allows the identification of
the chaperone domains and the location of Cdc37 and
Cdk4 in the complex, providing the first structural view
of client protein bound to the Hsp90 molecular chaper-
one and suggesting a mechanism for coupling the
Hsp90 ATPase cycle to conformational changes in
bound client protein kinases.
Results
Isolation and Compositional Analysis
of Hsp90-Cdc37-Protein Kinase Complex
Recombinant expression of Hsp90, Cdc37, and several
protein kinase clients in isolation has been reported pre-
viously by ourselves and others. However, assembly of
well-behaved and stoichiometric Hsp90-Cdc37-kinase
complexes by mixing purified proteins in vitro has
proven refractory, suggesting that other cellular factors
are probably involved in the client-loading process. We
sought to bypass this problem by coexpressing compo-
nents using a baculovirus vector in Sf9 cells (see Exper-
imental Procedures). Using this system, we could
express His6-tagged human Cdk4 and human B-Raf cat-
alytic domain at useful levels, in the presence of coex-
pressed human Cdc37. Fractionation of cell lysates by
using immobilized metal affinity chromatography
(IMAC) yielded coeluting Cdk4 and Cdc37, as well as
an w83 kDa protein. This was subsequently identified
by mass spectrometry (MS) as the Spodoptera frugi-
perda Hsp90 homolog, which is >70% sequence identi-
cal to human Hsp90a. Subsequent purification yielded
distinct fractions containing Hsp90, Cdc37, and Cdk4
(H-C-K) (Figure 1A) or Cdc37 and Cdk4 (C-K) (Figure 2A),
which eluted as single peaks in an analytical gel-filtration
column, indicating that they are homogeneous ternary
and binary complexes, respectively (Figures 1C and 2B).
Previous studies have shown that in the absence of
a client kinase, Cdc37 and Hsp90 interact in vitro as
dimers to form a (Cdc37)2-(Hsp90)2 complex (Roe et al.,
2004; Roiniotis et al., 2005; Zhang et al., 2004). To deter-
mine the stoichiometries of the in vivo-assembled H-C-K
and C-K complexes, the complexes were injected, using
nanoelectrospray ionization, into a modified tandem
time-of-flight (TOF) mass spectrometer (Waters Q-Tof2)
that allows analysis of assembled protein complexesby minimizing the energy of molecular collisions and
consequent dissociation of components (Sobott et al.,
2002). M/z spectra for the H-C-K complex identified the
presence of an (Hsp90)2-Cdc37-Cdk4 complex, in addi-
tion to some uncomplexed protein generated by colli-
sions in the spectrometer, but no larger species (Figures
1D and 1E). This stoichiometry is consistent with densi-
tometry of the Coomassie-stained complex, which
showed a 1:1 ratio of Cdc37 to Cdk4. The unusually
heavy staining of Hsp90 is also consistent with our den-
sitometry, which revealed Hsp90 to bind Coomassie in
a nonlinear fashion when calibrated against Cdc37 and
Cdk4 (Figure 1B). M/z spectra for the C-K fraction
showed the presence of a (Cdc37)2-Cdk4 complex, in
addition to some uncomplexed protein generated by col-
lisions in the spectrometer, but no larger assemblies
(Figures 2C and 2D). As the 2:1:1 stoichiometry of the
H-C-K complex was unexpected and in contradiction
of our previous predictions (Roe et al., 2004), we sought
to determine whether this was unique to complexes with
Cdk4, or whether it represents the normal stoichiometry
for stable Hsp90-Cdc37-kinase complexes. We there-
fore coexpressed the His6-tagged kinase domain of B-
Raf with Cdc37 in Sf9 cells (Wan et al., 2004) and purified
a B-Raf H-C-K complex in a similar fashion. As with the
Cdk4 complex, modified QTOF MS of the B-Raf H-C-K
complex identified an (Hsp90)2-Cdc37-B-Raf complex
as the largest species (see Figure S1 in the Supplemental
Data available with this article online).
EM and 3D Reconstruction of an (Hsp90)2-Cdc37-
Cdk4 Complex
The small asymmetric H-C-K complex particles (w245
kDa) were visualized in the electron microscope at
42,0003 magnification, stained with 2% uranyl acetate
(Figure3A). A total of4231 individualparticles werepicked
and aligned and grouped into classes by using multivari-
ate statistical analysis and hierarchical ascendant classi-
fication (see Experimental Procedures). Stable represen-
tative classes were used to generate a 3D volume by
angular reconstitution, which was iteratively refined to
give the final model. Reprojections of the final model cor-
respond well to the raw data (Figure 3B) and to the original
classes from before the angular reconstitution, unbiased
by the refinement process (Figure S2A). Particles showed
a good angular distribution with no significant problems
of preferred orientation (Figure S2B). The resolution of
the structure, estimated from the Fourier shell correlation
(FSC) coefficient of 0.5, isw19 A˚ (Figure S2C).
The reconstructed H-C-K complex has an elongated
structure that is w140–150 A˚ long and w85–95 A˚ in di-
ameter, resembling a candle flame: pointed at one end
and rounded at the other (Figure 4A). Two columns of
density twist around the long axis, connecting theFigure 1. Purification and Composition of the Hsp90-Cdc37-Cdk4 Ternary Complex
(A) 10% SDS-PAGE of purified H-C-K complex.
(B) Integrated optical density (IOD) for components of the H-C-K complex for four successive 2-fold dilutions in a Coomassie-stained 10% SDS-
PAGE. The IOD was normalized by calculated molecular weight of each component and further normalized against the smallest component,
Cdk4. The ratio of Cdc37 to Cdk4 remains 1:1 over successive dilutions, in agreement with results from MS (see Figure 1D). The Coomassie
binding of Hsp90 is nonlinear, possibly as a consequence of the protein’s very acidic nature.
(C) The final purification step is analytical gel filtration, and the chromatogram shows that the proteins run as a single species.
(D and E) The Nano-ESI TOF MS spectrum of the complex shows that the highest molecular weight species observed in the gas phase is
a complex comprising a dimer of Hsp90, a monomer of Cdc37, and a monomer of Cdk4. Masses calculated from the sequences are as follows:
Hsp90, 82,573 Da; Cdc37, 44,468 Da; Cdk4, 35,712 Da.
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Cdc37-Cdk4 Complex
(A) A typical micrograph of 2% uranyl ace-
tate-stained H-C-K showing views of the
complex. Only particles that were well sepa-
rated from the others and well stained were
picked for analysis. Examples are highlighted
in red.
(B) Reprojections from the model show fea-
tures that are recognizable in typical raw par-
ticles. Some masked, centered raw particles
retrospectively aligned to class averages
generated by classification after the final
alignment by projection matching. The corre-
sponding reprojections of the model are
shown below the class averages.base to the narrower tip (Figure 4B). A stain-filled cavity
evident in class sums corresponds to a channel of oval
cross-section running through the 3D structure, perpen-
dicular to the long axis. Views from opposite sides have
many similarities, and there is overall a roughly 2-fold
symmetry to the structure around the long axis. How-
ever, consistent with the 2:1:1 composition of the com-
plex, this symmetry is approximate and is clearly broken
by asymmetric distribution of density at the base and
by a tilt to one side of the tip of the candle flame.
Fitting of Protein Chains
Comparison of the 3D reconstruction with the crystal
structure of an Hsp90 dimer (Ali et al., 2006) shows many
points of similarity, validating our angular reconstitution
for this asymmetric complex (Figure 4C). Both crystal
and EM structures have very similar overall shapes and di-
mensions, with a pointed and a rounded end; both struc-
tures have a narrow channel running through them, and
both structures twist around the long axis (Figures 5A
and 5B). The handedness of this latter feature allows the
hand of the EM reconstruction to be fixed (Figure 5C). It
is immediately evident from comparison with the crystal
structure that the narrow tip of the EM volume corre-
sponds to the constitutively dimerized C-terminal do-
mains of Hsp90. The two partially symmetric longitudinal
columns of density therefore correspond to the two
Hsp90 monomers, with the N-terminal domains contribut-
ing to the rounded base of the reconstruction.
The columns of density connecting the tip and base
are very similar in overall shape to monomers of Hsp90
from the crystal structure, and features corresponding
to the three main segments of the Hsp90 crystal struc-
ture are readily discernible (Figures 5A and 5B). The in-
dividual monomers from the dimeric Hsp90 crystalstructure could be readily docked into the density man-
ually, maintaining the C-terminal dimerization interface.
Small changes in domain orientation, achieved by hing-
ing at the loop regions linking the domains, allow an ex-
cellent fit of the monomers to the reconstruction
(Figure 6A). These segments of polypeptide are known
to display considerable flexibility (see Discussion).
The N-terminal dimerization found in the crystal struc-
ture is not seen in the complex. Instead, the N-terminal
domain of one monomer is hinged backward, away
from its counterpart in the other monomer, such that
its relative orientation with respect to the middle domain
is opened like a jaw. For the second monomer, the larg-
est change in domain orientation is between the C-ter-
minal and middle domains, whereas orientation of the
N-terminal domain relative to the middle domain is sim-
ilar to that found in the crystal structure.
As well as the two Hsp90 molecules, the density of the
EM reconstruction must account for the single Cdc37
and Cdk4 molecules present in the complex. The globu-
lar domain in the C-terminal half of Cdc37 has previously
been shown to interact with the N-domain of Hsp90,
binding to the lid and open mouth of the nucleotide bind-
ing pocket and preventing its interaction with the middle
segment of the chaperone (Roe et al., 2004). The Hsp90
N-terminal domain from the crystal structure of the
Hsp90-Cdc37 complex can be superposed onto the N-
terminal domain of the ‘‘open’’ Hsp90 monomer
(Figure 6A) in the EM reconstruction. This positions the
Cdc37 C-terminal globular domain neatly into unoccu-
pied density between the densities assigned to the
two N-terminal domains of Hsp90.
The remaining unoccupied globular density is a bilobal
segment bridging the base of the structure to halfway up
one of the longitudinal columns. The lobes are ofFigure 2. Purification and Composition of the Cdc37-Cdk4 Binary Complex
(A) 10% SDS-PAGE of purified C-K complex.
(B) The final purification step is analytical gel filtration, and the chromatogram shows that the proteins run as a single species.
(C and D) The Nano-ESI TOF MS spectrum of the complex shows that the highest molecular weight species observed in the gas phase is a complex
comprising a dimer of Cdc37 and a monomer of Cdk4. Masses calculated from the sequences are as follows: Cdc37, 44,468 Da; Cdk4, 35,712 Da.
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the reconstruction, is smaller than the upper lobe con-
tacting the middle of one longitudinal column. The sizes
of these lobes are consistent with the N-terminal and C-
terminal lobes, respectively, of a cyclin-dependent ki-
nase catalytic domain (Figure 6A).
There is no distinct globular density that can be as-
signed to the N-terminal segment of Cdc37, whose
structure is currently unknown. However, there is con-
tinuous extra density around the N-terminal domain of
the second Hsp90 (Figure 6B). The orientation of the
docked C-terminal Cdc37 globular domain directs the
helix connecting to the N-terminal domain into this extra
density. As we find that Cdc37-pSer13 in the complex is
highly resistant to dephosphorylation (data not shown),
the N terminus of Cdc37 appears to be considerably
buried in the complex, and it is likely that it is subsumed
in the density at the base of the reconstruction, closely
associated with the Hsp90 N-terminal domains and the
kinase and probably in contact with both. No density
Figure 4. 3D Reconstruction of Hsp90-Cdc37-Cdk4 Complex
3D reconstruction of the H-C-K complex from negative-stain EM.
(A) Side views (related by 180 rotation around the vertical)—the
oval channel running through the center of the complex is immedi-
ately apparent, as are the two twisting columns of density connect-
ing the base to the tip. (B) End views showing the tip (right) and base
(left). (C) Secondary-structure cartoon (left) and molecular surface
(right) of the Hsp90 dimer crystal structure (Ali et al., 2006). Models
were generated using MacPyMOL (http://www.pymol.org).
for the C-terminal tail of Cdc37 is visible in the recon-
struction; however, on the basis of the orientation of
the docked Cdc37 globular domain, this helical segment
would be directed out of the complex into solvent and
would be unlikely to be well ordered. Indeed, in the crys-
tal structure of Cdc37 bound to the N terminus of Hsp90,
the C-terminal tail displayed high temperature factors
and was only visible as a result of a fortuitous crystal
contact (Roe et al., 2004). Consistent with the lack of
any direct involvement of this C-terminal tail in the com-
plex, the corresponding region has been shown to be
substantially dispensable for full biological function in
yeast (Lee et al., 2002).
Discussion
Conformational Flexibility of Hsp90
Comparison of Hsp90 crystal structures illustrates the
molecule’s considerable flexibility. For example, align-
ment of the middle domains of yeast Hsp90 (Ali et al.,
2006) with their equivalent in the E. coli homolog HtpG
Figure 5. Architecture of the Hsp90-Cdc37-Cdk4 Complex
(A and B) Different views of the EM reconstruction, rotated around the
vertical axis, and corresponding views of the crystal structure, fil-
tered to 20 A˚. Equivalent monomers in the crystal structure and the
EM reconstruction are outlined in black for each view. By comparison
of the two, domains of Hsp90 can be identified. Where one domain is
hidden behind another, the outline is colored yellow. There are some
interdomain movements on complexation with Cdc37 and Cdk4.
(C) The absolute hand of the EM reconstruction can be assigned by
matching the twist of the two structures. The C-terminal domain is
easily recognized, and therefore the polarity of Hsp90 within the
model can be determined.
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(A) The relative orientations of domains of the
crystal structure of Hsp90 are adjusted by
small rotations in the hinge regions and fitted
into the EM reconstruction. The location of M-
Cdc37 is determined by a least-squares fit of
the N-terminal domain of the open monomer
with N-Hsp90 from the crystal structure of
the complex with Cdc37. Cdk6 is used as
a model for Cdk4. The larger C-terminal
lobe of the kinase fills the larger lobe of the re-
construction and consequently is intimately
associated with the middle domain of one
Hsp90 monomer. The N-terminal lobe is
smaller and fills the remaining density, asso-
ciating with either the N-terminal domain of
Hsp90 or Cdc37, or both. Atomic models
are shown superimposed on their molecular
volumes filtered to 20 A˚ resolution. The EM
reconstruction is colored according to pro-
tein chain: Hsp90 open monomer, orange;
Hsp90 closed monomer, blue; Cdc37, green;
Cdk4, red.
(B) Orthogonal views of the pseudoatomic
model of the (Hsp90)2-Cdc37-Cdk4 complex
docked into the EM reconstruction. Some un-
assigned density in the vicinity of the Hsp90 N
termini (dotted outline) could accommodate
the N-terminal domain of Cdc37, whose
structure is not known but is predicted to
contain a segment of coiled coil and could
bridge to the N-terminal domain of the closed
Hsp90 monomer and/or the bound kinase.(Huai et al., 2005) reveals a huge translation and rotation
of the N domain in each structure with respect to the
other, such that the b sheets therein are now at right
angles. This degree of flexibility within the confines of
a crystal lattice reflects a much greater conformational
variability revealed by analysis of the Hsp90 dimer in
solution (Zhang et al., 2004). Indeed, difficulty in obtain-
ing crystals of the full-length protein that diffract to high
resolution can be attributed to this conformational vari-
ability. Success was ultimately dependent on trapping
Hsp90 in a defined functional and conformational state,
in complex with nucleotide and the cochaperone p23/
Sba1 (Ali et al., 2006).
Biochemical and structural data to date support an
ATP-driven molecular clamp mechanism (Prodromou
et al., 2000; Siligardi et al., 2004), and large conforma-
tional changes of the type described above are a prereq-
uisite for this. The Hsp90 dimer, constitutively dimerized
via its C-terminal domains, cycles between a state in
which the N-terminal domains are in an open, ATP-free
conformation, either held apart in a rigid manner by a di-
mer of the cochaperone Cdc37 (Roe et al., 2004) or sim-
ply unconstrained, and a closed or tense state in which
ATP is bound and a lid is closed over the ATP binding
site to expose a second, transient dimerization interfacebetween the two N-terminal domains (Ali et al., 2006;
Prodromou et al., 2000).
The flexibility required for such large structural
changes can been attributed to two linker regions that
join the N-terminal to middle, and middle to C-terminal
domains. The flexibility of these linkers is evident from
their susceptibility to proteolysis, and the stability of
the domains they connect when expressed in isolation.
In our model, the crystal structure of full-length Hsp90
fits into the EM reconstruction with relatively small ad-
justments of these linker regions. The dynamic nature
of Hsp90’s structure is therefore important not only for
the hydrolysis of ATP (Prodromou et al., 2000) and co-
chaperone binding (Meyer et al., 2004; Roe et al., 2004)
but also for enabling Hsp90 to adopt conformations,
such as we see in the current reconstruction, which al-
low client protein binding.
Protein Kinase and Cdc37 Interactions
A significant number of protein kinases form complexes
with Hsp90 and Cdc37 as a prerequisite to their activa-
tion (reviewed in Pearl [2005]), but the stoichiometry of
these complexes has not previously been determined.
For Cdk4 and for B-Raf, we have now observed a stable
complex containing an Hsp90 dimer bound to single
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the tagged kinase. Whether this stoichiometry is com-
mon to all kinase clients of Hsp90 is not known, but
that it occurs with two such distantly related kinases
suggests that this is likely to be the case. By contrast,
the Cdc37-Cdk4 complex devoid of Hsp90 contains
a single kinase bound to a dimer of Cdc37. We and
others have previously shown formation of an Hsp90-
Cdc37 complex in the absence of any kinase, consisting
of dimers of each (Roe et al., 2004; Roiniotis et al., 2005;
Zhang et al., 2004). Cdc37 is a dimer in isolation, but its
dissociation constant is low micromolar (Siligardi et al.,
2002), suggesting that it can exist happily in dimer or
monomer form. Taken together, these data point to an
ordered process of kinase client loading in which a ki-
nase-(Cdc37)2 complex initially binds to an Hsp90 dimer
via a symmetrical (Cdc37)2-(Hsp90)2 dimer-dimer inter-
action, as previously suggested (Roe et al., 2004), that
simultaneously arrests the ATPase cycle of Hsp90
(Siligardi et al., 2002). Subsequent conformational rear-
rangement of that initial complex could then release a
Cdc37 molecule to give the stable asymmetrical
(Hsp90)2-Cdc37-kinase complexes reported here (Fig-
ure S3). While this idea is fully consistent with the data,
further work will be required to substantiate it.
The channel between the Hsp90 protomers in the
complex clearly contradicts previous models (Roe
et al., 2004) in which a client is bound between the two
Hsp90 molecules in an analogy to ‘‘barrel’’ chaperonins
such as GroEL or CCT (Saibil, 2000). Instead, the client is
bound to the outer edge of one Hsp90 molecule, bridg-
ing its N-terminal and middle segments. The density at-
tributed to Cdk4 is distinctly bilobal, suggesting that the
two lobes of the kinase are in an extended conformation
compared with the mature protein. This could have
consequences for the ability of the kinase to bind nucle-
otide, since motifs from both lobes contribute to the ATP
binding site. Whether Cdk4 is competent to bind ATP,
cyclins, or CDK inhibitory proteins when part of the
Hsp90-Cdc37 complex is now the focus of further
work in our laboratory.
The larger lobe of the kinase clearly interacts with the
middle segment of one Hsp90 monomer, while the other
lobe is in a position to interact with the associated Hsp90
N-terminal domain and/or N-terminal part of the Cdc37
molecule anchored on the other Hsp90 N-terminal do-
main; these possibilities cannot be distinguished in the
present structure and may occur simultaneously. This
complex mode of interaction is consistent with studies
analyzing sites of interaction between Hsp90, Cdc37,
and a range of client protein kinases including ErbB2
(Xu et al., 2005), HRI (Scroggins et al., 2003), Lck (Prince
and Matts, 2004), as well as Cdk4 (Zhao et al., 2004), that
implicate the N-terminal lobe of the kinase as essential
for interactions with Hsp90 and Cdc37, while regions in
the kinase C terminus are involved in Hsp90 binding only.
Our interpretation of the bilobal segments, based on
their size (see Results), is fully consistent with these anal-
yses. In addition, the larger lobe of the kinase density
comes close to a hydrophobic patch centered on Trp300
in the middle segment of Hsp90 and shown by mutagen-
esis to be involved in client protein binding (Meyer et al.,
2003) (Figure 7). Part of this patch is contributed by
residues 328–338, which form an amphipathic loopprojecting from the body of the middle segment. The
considerable flexibility of this loop would give a degree
of tolerance allowing interaction with a range of client
proteins.
The bivalent interaction of the Cdk4, with one lobe
binding to the middle segment of Hsp90 and the other
to the N-terminal domain and/or Cdc37, provides a clear
mechanism for coupling ATP-dependent changes in the
relative conformation of the N-terminal and middle seg-
ments of Hsp90 (Chadli et al., 2000; Prodromou et al.,
2000) to changes in the orientation of the N and C lobes
of the bound kinase. As the relative positioning of these
lobes and the segment of protein that links them is well
known to play a significant role in regulating the activity
of many protein kinases (Johnson et al., 1996), associa-
tion with Hsp90 might be required to facilitate the switch
from an inactive to an active conformation in those
kinases where there is a high activation barrier to that
conformational change.
The N-terminal domain of Cdc37 has consistently
been shown to be necessary for kinase binding (Gram-
matikakis et al., 1999; Shao et al., 2001), while its C termi-
nus is responsible for interaction with Hsp90 (Roe et al.,
2004; Shao et al., 2001; Zhang et al., 2004). Nonetheless,
the extreme N-terminal part of Cdc37 also plays a role
in Hsp90 interactions in the context of a client protein
complex. Thus, while mutation of residues 2–4 of Cdc37
compromises binding of a client kinase but does not
affect Hsp90 binding (Scroggins et al., 2003), mutation
of Trp7 results in reduced binding for both client and
Hsp90. Phosphorylation of Ser13 in Cdc37 has been
shown to be essential for formation of productive Hsp90-
Cdc37-client complexes, but mutation of this residue
has no apparent effect on direct Hsp90-Cdc37 inter-
action (Miyata and Nishida, 2004; Shao et al., 2003b).
We find this phosphorylation to be present in the purified
baculovirus-expressed Cdc37 and in (Hsp90)2-Cdc37-
Cdk4 complexes. pSer13 in free Cdc37 is rapidly dephos-
phorylated by phosphatase treatment; however, in
marked contrast, pSer13 in the ternary (Hsp90)2-Cdc37-
Cdk4 complex was resistant to dephosphorylation,
Figure 7. Client Protein Interactions
Comparison of thew19 A˚ single-particle EM reconstruction (left) of
an (Hsp90)2-Cdc37-Cdk4 complex with the ATP bound Hsp90 crys-
tal structure (right). The bilobal kinase client (red) appears to interact
with the N domain of one Hsp90 protomer and a region on the middle
segment close to Trp300 (red on left), which is implicated in client
protein binding. Changes in relative position of these Hsp90 do-
mains coupled to the ATPase cycle would be transmitted to the
bound client protein.
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Taken together, these data suggest that the extreme
N-terminal segment of Cdc37 incorporating pSer13
cements the interaction between Hsp90 and the kinase
client, possibly becoming bound between them in the
ternary complex.
In our model, the N-terminal segment of Cdc37 would
stretch across the base of the complex toward the
bound Cdk4 and the other Hsp90 N-terminal domain, al-
lowing residues at its N terminus to interact with both as
suggested by the mutational and accessibility data. This
is also consistent with the additional observation that
the residues in Cdc37 that connect its N-terminal and
C-terminal domains regulate both Hsp90 and kinase
binding, since it is this subdomain of Cdc37 that would
bridge between the N-terminal domains of the two
Hsp90 monomers (Shao et al., 2003b).
A recent study examining the client binding site on
Cdc37 isolated a hydrophobic 20-residue peptide corre-
sponding to residues 181–200 of Cdc37 that could ap-
parently coprecipitate Raf-1 kinase domain from COS-
7 cells (Terasawa and Minami, 2005). The significance
of this observation is uncertain, as these residues are
substantially buried in the globular domain of Cdc37
that binds the N-terminal domain of Hsp90 (Roe et al.,
2004). Furthermore, these results directly conflict with
earlier studies in COS-1 and Sf9 cells, which showed
that the Raf-1 kinase binding site on Cdc37 resides in
the N-terminal half of the protein (residues 1–164)
(Grammatikakis et al., 1999) and that truncation of
Cdc37 beyond residue 164 results in loss of Hsp90
from the Cdc37-Raf-1 complex, consistent with our
crystallographic data (Roe et al., 2004).
Conclusion
The EM reconstruction presented here provides a first
experimental view of a client-loaded Hsp90 complex.
The exact orientation of each domain within the com-
plex, the nature of the interaction of the N-terminal do-
main of Cdc37 with Hsp90 and Cdk4, and the detailed in-
teractions of residues at the protein-protein interfaces
within the complex cannot be resolved at the resolution
accessible with negative-stain EM. Nevertheless, within
the context of these limitations, the composition and ar-
chitecture of the Hsp90-Cdc37-kinase complex can be
defined and our interpretation is consistent with a large
body of crystallographic, biochemical, and genetic data
published to date.
This complex was isolated in the presence of sodium
molybdate, which has been widely used to stabilize
complexes of steroid hormone receptors and other tran-
scription factors with Hsp90 (Pratt and Toft, 1997) and
which has the same effect here (see Experimental Pro-
cedures). Molybdate is believed to act as a mimetic of
the ATP g-phosphate, occupying Hsp90’s ATP binding
site in combination with ADP to inhibit the ATPase cycle
and trap the complex with the client in a preactivated
‘‘early’’ state. The precise position in the chaperone cy-
cle that our reconstruction represents is not known.
However, the presence of one Cdc37 molecule suggests
that it is also an early complex, trapped somewhere be-
tween initial complex formation, which involves a Cdc37
dimer (Siligardi et al., 2002; Zhang et al., 2004), and the
catalytically competent ATP bound conformation (Aliet al., 2006), progression to which requires complete
disengagement of Cdc37 from the Hsp90 N domains.
In any event, this complex is only one of a number of
modes of interaction that a client makes with Hsp90
and Cdc37 during the chaperone’s ATPase cycle, and
further work will be required to identify and isolate the
other client bound intermediates that may occur.
Many key questions related to the detailed interac-
tions involved remain to be answered. It is only those de-
tails that will lead to a full understanding of how Hsp90
and Cdc37 facilitate activation of client protein kinases,
and to a determination of what features of the client pro-
teins are responsible for their specific requirement for,
and recruitment to, the Hsp90-Cdc37 chaperone sys-
tem. Full activation of Cdk4, downstream of Hsp90 bind-
ing, requires phosphorylation of the activation loop, and
complexation with cyclin D (Kato et al., 1994). Whether
these steps take place in the context of Hsp90 is at pres-
ent unknown, but the Hsp90-Cdc37-Cdk4 complex
provides a robust system with which to address these
questions.
Experimental Procedures
Expression and Purification of Proteins
A modified pFastBac DUAL (Invitrogen) expression vector was
made by inserting an intergenic region, encoding a His6 tag, be-
tween BamHI and EcoRI of multiple cloning site I (MCS I). This mod-
ification also encoded an NheI restriction site immediately 30 to the
His6 tag. The CDK4 gene was amplified by PCR. The primers used
encoded a BamHI and NheI restriction site, and a PreScission cleav-
age site, all 50 to the gene, and a HindIII restriction site 30 to the gene.
The BamHI-HindIII fragment was cloned into pET28a (Novagen).
Subsequently, the NheI-NotI fragment was cloned into our modified
MCS I of pFastBac DUAL. Cloning of human Cdc37 has been de-
scribed previously (Siligardi et al., 2002). A XhoI/KpnI PCR fragment
of Cdc37 was cloned into MCS II of the pFastBac DUAL vector.
Proteins were expressed in Sf9 cells over 3 days. The cell pellet
was lysed by homogenization in TBS-Mo buffer (25 mM Tris-HCl
[pH 7.5], 150 mM NaCl, 10 mM KCl, 10 mM MgCl2, and 20 mM
Na2MoO4) with 25 mM NaF, 25 mM b-sodium glycerophosphate,
and EDTA-free complete protease inhibitor tablets (Roche). Cdc37
and Cdk4 coeluted with endogenous Sf9 Hsp90 (H-C-K) from
TALON resin (BD Biosciences). Gel filtration on a Superdex200 HR
column (GE Healthcare) with TBS-Mo buffer; desalting into TBS-
Mo without NaCl, followed by ion exchange using Q-Source resin
(GE Healthcare); and analytical gel filtration on a Superose 6
HR10/30 (GE Healthcare) column with TBS-Mo buffer were used to
purify the complex to homogeneity. The complex could also be
isolated by using the same protocol in the absence of sodium
molybdate; however, the yields were considerably reduced.
Baculovirus-expressed Hsp90-Cdc37-B-Raf complex was purifed
as described (Wan et al., 2004).
Nano-ESI TOF MS
Samples for MS analysis were buffer exchanged into 100 mM ammo-
nium acetate (pH 7), using Micro Bio-Spin 6 columns (Bio-Rad).
Nano-ESI capillaries were prepared in-house from borosilicate glass
tubes of 1 mm outer and 0.5 mm inner diameter (Harvard Apparatus,
Holliston, Massachusetts) using a Flaming/Brown P-97 micropipette
puller (Sutter Instruments, Hercules, California) and were gold
coated using a sputter coater (Quorum Technologies, Newhaven,
United Kingdom). Capillary tips were cut under a stereomicroscope
to give inner diameters of 1–5 mm, and typically 2 ml of solution was
loaded for sampling. Mass spectra were recorded on a tandem mass
spectrometer (Waters Q-Tof2, Manchester, United Kingdom) that
was modified for high-mass operation (Sobott et al., 2002), and pres-
sures and accelerating potentials were adjusted to preserve nonco-
valent interactions (Heck and Van Den Heuvel, 2004; Sobott and
Robinson, 2002). Data were acquired and processed with MassLynx
software (Waters, Manchester, United Kingdom).
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HCK complex at 10–15 mg/ml was stained on carbon-coated copper
grids with 2% (w/v) uranyl acetate after glow discharging in the pres-
ence of pentyl-amine. Samples were imaged in an FEI Tecnai T12
electron microscope (FEI, Eindhoven, The Netherlands) operating
at 120kV and were recorded in low-dose mode at a defocus of
around 0.5 mm on Kodak SO163 film at 42,0003 magnification. Mi-
crographs were digitized on a Zeiss PhotoScan LD linear array scan-
ner at 14 mm/pixel (3.33 A˚/pixel at the specimen level).
Image Processing
Defocus and astigmatism were determined using CTFfind3 (Mindell
and Grigorieff, 2003). Boxed particles from 35 micrographs were im-
ported into IMAGIC (van Heel et al., 1996) for all further processing. A
total of 4231 particles were centered using three rounds of transla-
tional alignment to the rotationally averaged total sum. Multivariate
statistical analysis and hierarchical ascendant classification were
used to generate reference classes to which all particles were
aligned. This process was repeated iteratively. Well-defined classes
representing distinct views of the complex were chosen for angular
reconstitution to generate an initial model. Additional classes were
incorporated into the model with increasing Euler angle precision
in three rounds of anchor set refinement.
At this point, the reconstruction was 3D masked and refined by
projection matching. For each iteration, the angle assignments
were sorted by reprojection error (agreement between the average
for each orientation and the corresponding reprojection) and visually
checked to ensure that the classes were acceptable. A 3D map was
then created from the acceptable classes.
The model was determined to be fully refined after eight rounds of
projection matching, when the percentage of total particles chang-
ing class between successive rounds and the value of the FSC coef-
ficient at 0.5 had converged. At this stage, there was no visible
change in the reconstruction between rounds of refinement. The fi-
nal reconstruction was generated using 190 out of a total of 412
class sums, containing 76.8% of the data, but a map with all 412
sums was not noticeably different.
Model Building
The anticlockwise twist of the crystal structure of full-length Hsp90
(Ali et al., 2006) was used to assign the hand of the EM map.
All crystal structures used for model building (Hsp90, PDB code
2CGE, 2CG9; Cdk6, PDB code 1J0W; N-Hsp90-C-Cdc37, PDB
code 1US7) were filtered to 20 A˚ using the Situs program PDBlur
(Wriggers et al., 1999) to allow a direct comparison with the EM re-
construction. All docking was carried out manually in MacPyMOL
(www.pymol.org).
Supplemental Data
Supplemental Data include three figures and Supplemental Refer-
ences and can be found with this article online at http://www.
molecule.org/cgi/content/full/23/5/697/DC1/.
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